RecruitingNCT07561567

Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

A Single Center, Translational Study on the Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Patients Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device


Sponsor

Tianjin Medical University Cancer Institute and Hospital

Enrollment

50 participants

Start Date

May 10, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is: Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors? Participants will: Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Clinical diagnosis is solitary peripheral lung cancer, and after comprehensive evaluation by the participating physicians based on the patient's clinical data, it is suitable for receiving SBRT treatment;

Exclusion Criteria1

  • Central or super central lung cancer patients who are intolerant or unwilling to undergo respiratory suppression and chest and abdominal compression fixation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEChest and abdominal compression

Abdominal compression suppresses respiratory movement in patients

DEVICEbreathing management

Apply pressure to the patient's abdomen to achieve respiratory movement inhibition


Locations(1)

Tianjin Medical University Cancer Institute and Hospital

Tianjin, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07561567


Related Trials